Envista Holdings Corporation

NVST Healthcare Medical Instruments & Supplies

Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.

Revenue
+3.22%
EPS
+1,855.6%
Free cash flow
−6.48%
Total debt
−1.13%

Quarter to September 2026, against a year earlier

24.98 2.21 −8.13%
Market cap
$4.0B
P/E
6.4×
Fwd P/E
21.5×
Dividend yield
—
F-score
7/9
Altman Z
1.59
Beneish M
−2.50
Dividend safety
n/a

Envista Holdings Corporation (NVST) Operating cash flow

Alert me on Operating cash flow

Envista Holdings Corporation's operating cash flow for fiscal 2025 was $275.7M, down 18.1% from $336.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was $301.8M. Over the past ten years it has ranged from $182.7M (fiscal 2022) to $417.0M (fiscal 2016); the current reading is higher than 30% of that period. Envista Holdings Corporation ranks 14th of 51 Medical Instruments & Supplies companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $275.7M (18.07%)
FY2024 $336.5M 22.05%
FY2023 $275.7M 50.90%
FY2022 $182.7M (49.47%)
FY2021 $361.6M 27.37%
FY2020 $283.9M (28.58%)
FY2019 $397.5M (0.65%)
FY2018 $400.1M 11.42%
FY2017 $359.1M (13.88%)
FY2016 $417.0M —

Quarterly newest first

Period Operating cash flow Change
Sep 2026 $77.9M (34.65%)
Jun 2026 $119.2M —
Mar 2026 −$3.3M —
Dec 2025 $108.0M 37.23%
30 more quarters

Against its own ten years

Low $182.7M High $417.0M
Ten-year median $347.8M
Current reading's percentile 30

Operating cash flow against peers

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on NVST